Diag-Nose Medical Pty Ltd
This research study is an observational, single site study quantifying expression of biomarkers of respiratory disease in nasal fluid using the ABEL microsampler device. The primary objective of this study is to compare biomarker expression between healthy controls and participants with respiratory disorders such as chronic obstructive pulmonary disorder (COPD), hayfever, chronic sinusitis, asthma and rhinitis.
Chronic Obstructive Pulmonary Disease (COPD)
Asthma Patients
Asthma and Rhinitis
Asthmatic Patients
Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Rhinitis Allergic
Rhinitis, Allergic, Perennial and/or Seasonal
Non-allergic rhinitis
Chronic Sinusitis With or Without Nasal Polyps
Healthy Volunteers
ABEL microsampler device
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 250 participants |
| Official Title : | Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders |
| Actual Study Start Date : | 2025-01-08 |
| Estimated Primary Completion Date : | 2025-07 |
| Estimated Study Completion Date : | 2026-07 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Diag-Nose Medical
Notting Hill, Victoria, Australia, 3168